Effect of DOAC-Remove on coagulation screening assays in samples from patients receiving oral or parenteral anticoagulationYY

被引：5
作者：
Al-Qawzai, Zahra [1 ,2 ]
Dale, Chris [1 ,3 ]
Dave, Minal [1 ,3 ]
Yartey, Nada [1 ,3 ]
Platton, Sean [1 ,4 ]
机构：
[1] Royal London Hosp, Barts Hlth NHS Trust, NHS East & South East London Pathol Partnership, London, England
[2] Royal London Hosp, Barts Hlth NHS Trust, Clin Biochem Lab, London, England
[3] Royal London Hosp, Barts Hlth NHS Trust, Haemostasis Lab, London, England
[4] Royal London Hosp, Barts Hlth NHS Trust, Haemophilia Ctr, London, England
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2022年 / 44卷 / 03期
关键词：
D O I：
10.1111/ijlh.13743
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E95 / E99
页数：5
相关论文
共 11 条
[1]   Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review [J].
Adcock, D. M. ;
Gosselin, R. .
THROMBOSIS RESEARCH, 2015, 136 (01) :7-12
[2]  
[Anonymous], 2004, HUMAN TISSUE ACT
[3]   A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC-Remove [J].
Cox-Morton, Sally ;
MacDonald, Stephen ;
Thomas, Will .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (03) :377-385
[4]   The effect of DOACs on laboratory tests and their removal by activated carbon to limit interference in functional assays [J].
Exner, Thomas ;
Rigano, Joseph ;
Favaloro, Emmanuel J. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 :41-48
[5]   Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy? Implications for pathology testing [J].
Favaloro, Emmanuel J. ;
Pasalic, Leonardo ;
Lippi, Giuseppe .
PATHOLOGY, 2017, 49 (06) :639-643
[6]   Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays [J].
Gosselin, R. ;
Grant, R. P. ;
Adcock, D. M. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (05) :505-513
[7]   International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants [J].
Gosselin, Robert C. ;
Adcock, Dorothy M. ;
Bates, Shannon M. ;
Douxfils, Jonathan ;
Favaloro, Emmanuel J. ;
Gouin-Thibault, Isabelle ;
Guillermo, Cecilia ;
Kawai, Yohko ;
Lindhoff-Last, Edelgard ;
Kitchen, Steve .
THROMBOSIS AND HAEMOSTASIS, 2018, 118 (03) :437-450
[8]   Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants [J].
Jourdi, Georges ;
Delrue, Maxime ;
Stepanian, Alain ;
Valaize, Jessica ;
Foulon-Pinto, Geoffrey ;
Demagny, Julien ;
Duchemin, Jerome ;
Nedelec-Gac, Fabienne ;
Darnige, Luc ;
Curis, Emmanuel ;
Delavenne, Xavier ;
Gaussem, Pascale ;
Siguret, Virginie ;
Gouin-Thibault, Isabelle .
THROMBOSIS RESEARCH, 2019, 184 :86-91
[9]   Guidelines on the investigation and management of antiphospholipid syndrome [J].
Keeling, David ;
Mackie, Ian ;
Moore, Gary W. ;
Greer, Ian A. ;
Greaves, Michael .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (01) :47-58
[10]  
Kitchen S., 2010, Diagnosis of Hemophilia and Other Bleeding Disorders: A laboratory manual
12